104
Views
21
CrossRef citations to date
0
Altmetric
Original

Low‐field MRI for assessing synovitis in patients with rheumatoid arthritis. Impact of Gd‐DTPA dose on synovitis scoring

, , , , , , , , & show all
Pages 277-282 | Received 22 Dec 2005, Accepted 17 Mar 2006, Published online: 12 Jul 2009
 

Abstract

Objective: To investigate the impact of a double dose compared to a single dose of contrast material in low‐field magnetic resonance imaging (MRI) on semi‐quantitative scoring of synovitis in patients with rheumatoid arthritis (RA).

Methods: This prospective study included 38 RA patients (23 women and 15 men, mean age 51 years). All patients underwent low‐field MRI of the hand before administration of contrast medium, after intravenous injection of 0.1 mmol/kg gadolinium diethylenetriaminepentaacetic acid (Gd‐DTPA), and after another dose of 0.1 mmol/kg Gd‐DTPA. Two readers (A and B) blinded to dosage independently scored the single dose and double dose image sets for synovitis according to outcome measures in rheumatology (OMERACT) recommendations. Contrast‐to‐noise ratio (CNR) and signal‐to‐noise ratio (SNR) were also calculated for each set.

Results: 149 metacarpophalangeal (MCP) joints were evaluated. There was good inter‐reader agreement for each of the two sets (intra‐class correlation coefficient of 0.75 for the single dose set and 0.83 for the double dose). Median CNR and SNR values were 5.4 and 15.9, respectively, for the single dose set and 8.5 and 16.6, respectively, for the double dose set (p<0.0001). Single dose set mean synovitis scores were 1.7 and 1.6 for readers A and B, respectively. Double dose set scores were 1.9 and 2.0, respectively. Thus, higher synovitis scores were recorded for the double dose sets than the single dose sets (p<0.005).

Conclusion: In low‐field MRI, when evaluating RA, the dose of the contrast material influences synovitis scoring. Therefore, dosage of contrast material should be taken into consideration when using extremity dedicated low‐field MRI.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.